IBDEI0Z6 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15693,2)
 ;;=^5007120
 ;;^UTILITY(U,$J,358.3,15694,0)
 ;;=I25.700^^88^867^21
 ;;^UTILITY(U,$J,358.3,15694,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15694,1,3,0)
 ;;=3^Athscl of CABG,Unspec w/ Unstable Angina Pectoris
 ;;^UTILITY(U,$J,358.3,15694,1,4,0)
 ;;=4^I25.700
 ;;^UTILITY(U,$J,358.3,15694,2)
 ;;=^5007117
 ;;^UTILITY(U,$J,358.3,15695,0)
 ;;=I82.469^^88^867^24
 ;;^UTILITY(U,$J,358.3,15695,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15695,1,3,0)
 ;;=3^Embolism/Thrombosis,Unspec Calf Muscle Vein,Acute
 ;;^UTILITY(U,$J,358.3,15695,1,4,0)
 ;;=4^I82.469
 ;;^UTILITY(U,$J,358.3,15695,2)
 ;;=^5158066
 ;;^UTILITY(U,$J,358.3,15696,0)
 ;;=I82.569^^88^867^25
 ;;^UTILITY(U,$J,358.3,15696,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15696,1,3,0)
 ;;=3^Embolism/Thrombosis,Unspec Calf Muscle Vein,Chronic
 ;;^UTILITY(U,$J,358.3,15696,1,4,0)
 ;;=4^I82.569
 ;;^UTILITY(U,$J,358.3,15696,2)
 ;;=^5158074
 ;;^UTILITY(U,$J,358.3,15697,0)
 ;;=I80.259^^88^867^33
 ;;^UTILITY(U,$J,358.3,15697,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15697,1,3,0)
 ;;=3^Phlebitis & Thrombophlebitis,Unspec Calf Muscle Vein
 ;;^UTILITY(U,$J,358.3,15697,1,4,0)
 ;;=4^I80.259
 ;;^UTILITY(U,$J,358.3,15697,2)
 ;;=^5158058
 ;;^UTILITY(U,$J,358.3,15698,0)
 ;;=I82.409^^88^867^26
 ;;^UTILITY(U,$J,358.3,15698,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15698,1,3,0)
 ;;=3^Embolism/Thrombosis,Unspec Deep Vein,LE Unspec Acute
 ;;^UTILITY(U,$J,358.3,15698,1,4,0)
 ;;=4^I82.409
 ;;^UTILITY(U,$J,358.3,15698,2)
 ;;=^5133625
 ;;^UTILITY(U,$J,358.3,15699,0)
 ;;=I82.509^^88^867^27
 ;;^UTILITY(U,$J,358.3,15699,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15699,1,3,0)
 ;;=3^Embolism/Thrombosis,Unspec Deep Vein,LE Unspec Chronic
 ;;^UTILITY(U,$J,358.3,15699,1,4,0)
 ;;=4^I82.509
 ;;^UTILITY(U,$J,358.3,15699,2)
 ;;=^5133628
 ;;^UTILITY(U,$J,358.3,15700,0)
 ;;=E78.1^^88^868^23
 ;;^UTILITY(U,$J,358.3,15700,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15700,1,3,0)
 ;;=3^Pure Hyperglyceridemia
 ;;^UTILITY(U,$J,358.3,15700,1,4,0)
 ;;=4^E78.1
 ;;^UTILITY(U,$J,358.3,15700,2)
 ;;=^101303
 ;;^UTILITY(U,$J,358.3,15701,0)
 ;;=E78.2^^88^868^21
 ;;^UTILITY(U,$J,358.3,15701,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15701,1,3,0)
 ;;=3^Mixed Hyperlipidemia
 ;;^UTILITY(U,$J,358.3,15701,1,4,0)
 ;;=4^E78.2
 ;;^UTILITY(U,$J,358.3,15701,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,15702,0)
 ;;=I10.^^88^868^9
 ;;^UTILITY(U,$J,358.3,15702,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15702,1,3,0)
 ;;=3^Essential Primary Hypertension
 ;;^UTILITY(U,$J,358.3,15702,1,4,0)
 ;;=4^I10.
 ;;^UTILITY(U,$J,358.3,15702,2)
 ;;=^5007062
 ;;^UTILITY(U,$J,358.3,15703,0)
 ;;=I11.9^^88^868^19
 ;;^UTILITY(U,$J,358.3,15703,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15703,1,3,0)
 ;;=3^Hypertensive Heart Disease w/o Heart Failure
 ;;^UTILITY(U,$J,358.3,15703,1,4,0)
 ;;=4^I11.9
 ;;^UTILITY(U,$J,358.3,15703,2)
 ;;=^5007064
 ;;^UTILITY(U,$J,358.3,15704,0)
 ;;=I11.0^^88^868^18
 ;;^UTILITY(U,$J,358.3,15704,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15704,1,3,0)
 ;;=3^Hypertensive Heart Disease w/ Heart Failure
 ;;^UTILITY(U,$J,358.3,15704,1,4,0)
 ;;=4^I11.0
 ;;^UTILITY(U,$J,358.3,15704,2)
 ;;=^5007063
 ;;^UTILITY(U,$J,358.3,15705,0)
 ;;=I12.0^^88^868^15
 ;;^UTILITY(U,$J,358.3,15705,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15705,1,3,0)
 ;;=3^Hypertensive Chr Kidney Disease w/ ESRD
 ;;^UTILITY(U,$J,358.3,15705,1,4,0)
 ;;=4^I12.0
